Boosting ‘Good' Gut Bacteria Could Lower Risk Of Lymphoma

Bolstered by the consumption of probiotics, “good” intestinal bacteria could decrease the risk of developing lymphoma, according to a new study conducted by UCLA researchers.

Bacteria in the gut are split into a pair of categories: harmful bacteria that sparks inflammation, and the beneficial type with anti-inflammatory properties. Researchers believe that positive intestinal bacteria is just one of many healthy options people can make to prevent or delay the onset of lymphoma.

Gut bacteria

A previous study by UCLA proposed a link between intestinal microbiota and the onset of lymphoma. For this study, the researchers examined mice possessing a mutated gene believed to be responsible for lymphoma and other cancers.

One group was given a combination of anti-inflammatory and inflammatory microbes, and the other was administered only anti-inflammatory bacteria. The researchers claim that the mice given only anti-inflammatory bacteria saw a significant delay in the onset of lymphoma.

Researchers are now taking a closer look at how microbiota delays and prevents the onset of lymphoma. They hope that clinicians can prescribe probiotics in the future as a cost-effective and non-intrusive way to battle cancer.

“It is not invasive and rather easy to do,” said Dr. Robert Schiestl, senior author of the study. “In the future, it is our hope that the use of probiotics-containing [supplements] would be a potential chemopreventive for normal humans, while the same type of microbiota would decrease tumor incidence in cancer susceptible populations.”

Source: Lymphoma News Today

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap